Yield10 Bioscience, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Yield10 Bioscience is set to sell substantially all of its assets to Nuseed Nutritional US Inc. and subsequently liquidate and dissolve the company, pending stockholder approval.
OTC.Pink
Yield10 Bioscience is holding its 2024 annual meeting to vote on key proposals including increasing authorized shares, approving warrant issuance, and executive compensation.
OTC.Pink
DEF 14A: Yield10 Bioscience Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
Yield10 Bioscience is asking stockholders to approve a reverse stock split to increase its share price and maintain its Nasdaq listing.